Inhibition of acyl-coenzyme A:cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes.
We investigated the mechanism of spontaneous cholesterol efflux induced by acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibition, and how an alteration of cholesterol metabolism in macrophages impacts on that in HepG2 cells. Oleic acid anilide (OAA), a known ACAT inhibitor reduced lipid storage substantially by promotion of cholesterol catabolism and repression of cholesteryl ester accumulation without further increase of cytotoxicity in acetylated low-density lipoprotein-loaded THP-1 macrophages. Analysis of expressed mRNA and protein revealed that cholesterol 7alpha-hydroxylase (CYP7A1), oxysterol 7alpha- hydroxylase (CYP7B1), and cholesterol 27-hydroxylase (CYP27) were highly induced by ACAT inhibition. The presence of a functional cytochrome P450 pathway was confirmed by quantification of the biliary cholesterol mass in cell monolayers and extracelluar medium. Notably, massively secreted biliary cholesterol from macrophages suppressed the expression of CYP7 proteins in a farnesoid X receptor (FXR)-dependent manner in HepG2 cells. The findings reported here provide new insight into mechanisms of spontaneous cholesterol efflux, and suggest that ACAT inhibition may stimulate cholesterol-catabolic (cytochrome P450) pathway in lesion-macrophages, in contrast, suppress it in hepatocyte via FXR induced by biliary cholesterol (BC).
An
Sojin
S
National Research Laboratory of Lipid Metabolism and Atherosclerosis, KRIBB, Daejeon, Korea.
Jang
Young-Soon
YS
Park
Ji-Seon
JS
Kwon
Byoung-Mog
BM
Paik
Young-Ki
YK
Jeong
Tae-Sook
TS
D000813:Anilides / Q000494:pharmacology*; D001646:Bile / Q000378:metabolism; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D002788:Cholesterol Esters / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000819:agonists / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects / Q000235:genetics; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008954:Models, Biological; D009829:Oleic Acids / Q000494:pharmacology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000378:metabolism*; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors* / Q000502:physiology; D014157:Transcription Factors / Q000819:agonists / Q000378:metabolism*; D000099150:Receptor, Farnesoid X-Activated
D000813:Anilides; D002784:Cholesterol; D002788:Cholesterol Esters; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D009829:Oleic Acids; D018160:Receptors, Cytoplasmic and Nuclear; D002785:Sterol O-Acyltransferase; D014157:Transcription Factors; D000099150:Receptor, Farnesoid X-Activated; C038731:oleoylanilide
Proc Soc Exp Biol Med. 1952 Dec;81(3):720-4
13037778
Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):121-6
11788471
J Biol Chem. 2002 Nov 8;277(45):43271-80
12215451
J Biol Chem. 1990 Jul 15;265(20):12012-9
1694852
J Clin Invest. 1994 Jun;93(6):2463-72
8200982
J Med Chem. 1998 Mar 26;41(7):1007-10
9544199
J Biol Chem. 1995 Mar 17;270(11):5772-8
7890706
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):325-42
16922646
Atherosclerosis. 2005 Apr;179(2):229-36
15777536
Annu Rev Nutr. 2003;23:303-13
12626688
Biochem Biophys Res Commun. 2003 Oct 3;309(4):864-72
13679053
Exp Mol Med. 2005 Dec 31;37(6):559-66
16391517
Arch Biochem Biophys. 2000 Sep 15;381(2):273-7
11032415
Biochim Biophys Acta. 1995 Jun 6;1256(3):353-9
7786899
J Clin Invest. 2002 Apr;109(7):961-71
11927623
Endocr Rev. 2002 Oct;23(5):687-702
12372848
Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2199-206
10479663
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11323-8
16844773
Atherosclerosis. 2002 Mar;161(1):45-54
11882316
Adv Lipid Res. 1968;6:1-68
4179999
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):13-27
11145929
J Biol Chem. 2000 Apr 14;275(15):10918-24
10753890
Am Heart J. 2006 Jul;152(1):67-74
16824833
J Med Chem. 1992 May 1;35(9):1609-17
1578488
J Lipid Res. 2004 Aug;45(8):1538-45
15145977
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):142-54
11111084
J Clin Invest. 1987 Feb;79(2):418-26
3805276
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):122-7
15499046
J Lipid Res. 2003 Oct;44(10):1956-62
12897188
Proc Natl Acad Sci U S A. 1979 Jan;76(1):333-7
218198
Science. 2002 May 31;296(5573):1703-6
11988537
Cell. 1999 May 28;97(5):539-42
10367881
J Lipid Res. 2002 Apr;43(4):629-35
11907146
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2316-21
16825595
Exp Mol Med. 2007 Aug 31;39(4):524-34
17934341
Hepatology. 1999 Aug;30(2):491-500
10421659
J Biol Chem. 2001 Oct 19;276(42):38378-87
11504730
FASEB J. 2003 Apr;17(6):746-8
12594184
Gene. 2001 Jan 10;262(1-2):257-65
11179691
J Lipid Res. 2002 Dec;43(12):2037-41
12454263
J Steroid Biochem. 1990 Aug 28;36(6):631-40
2214780
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3178-82
184464
Mol Cell. 2000 Sep;6(3):517-26
11030332
Circulation. 2004 Nov 23;110(21):3372-7
15533865
Mol Endocrinol. 2002 Jul;16(7):1590-7
12089353